VITA 34 International AG: Positive Results in Q2 2009

VITA 34 International AG / Half Year Results/Forecast

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

* EBIT at EUR 16k plus following EUR 0.8 million loss 
* Revenues in Q2 slightly above last year
* 2009 annual targets confirmed

Leipzig, July 14, 2009 - VITA 34 International AG (ISIN DE000A0BL849), the
parent company of the leading umbilical cord blood bank in the
German-speaking countries, VITA 34, has returned to profitability in the
second quarter of 2009. The earnings before interest and taxes (EBIT)
improved to more than EUR 16k following a loss of EUR 0.8 million in the
corresponding quarter the year before. The period earnings turned around
from EUR -0.8 million the year before to more than EUR 68k. Thus, the
planned, just about two-year loss phase of the company was ended, during
which high expenditures were incurred for sales and marketing, in order to
further optimize the company's market position. In the first half of 2009
EBIT improved clearly to EUR -0.2 million, up from EUR -1.2 million the
prior year.

Revenues increased in Q2 2009 to EUR 3.6 million, and were, therefore,
slightly higher that the corresponding quarter the year before. In the
first half of 2009 revenues were EUR 7.0 million, following EUR 7.2 million
in the first half year of 2008. The equity ratio of some 61 percent was
slightly higher than the 60 percent reported as of December 31, 2008.

Thanks to the developments of the first half-year, VITA 34 believes it is
fully on track for the entire year 2009. The goal is to achieve at least a
black zero with regard to EBIT.

This Tuesday at 11:30 AM VITA 34 will be holding a telephone conference for
analysts and the media to explain additional details on the development of
business. Those interested in participating can obtain the required access
data from edicto GmbH at Tel. +49 (069) 905505-53 or from

The complete quarterly report is available for download at in
the Investor Relations Section.

Press/Investor Relations:
Axel Mühlhaus
Dr. Sönke Knop
edicto GmbH
Zeisselstraße 19
D-60318 Frankfurt
Tel.:+49 (069) 90550550
Fax: +49 (069) 90550577

14.07.2009  Financial News transmitted by DGAP
Language:     English
Issuer:       VITA 34 International AG
              Deutscher Platz 5a
              04103 Leipzig
Phone:        +49(0341)48792-40
Fax:          +49(0341)48792-39
ISIN:         DE000A0BL849
WKN:          A0BL84
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, München, Hamburg, Stuttgart
End of News                                     DGAP News-Service